CYCLO THERAPEUTICS, INC. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/215ee5d4-d2fa-41ca-9259-6618d5632be2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-20.1M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-008181 |
| FY 2022 | $-15.5M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-007064 |
| FY 2021 | $-14.3M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-006039 |
| FY 2020 | $-8.9M | 2020-01-01 – 2020-12-31 | evidence 0001437749-21-026724 |
| FY 2019 | $-7.5M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-011000 |
| FY 2018 | $-4.3M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-005049 |
| FY 2017 | $-3.8M | 2017-01-01 – 2017-12-31 | evidence 0001437749-18-006934 |
| FY 2016 | $-4.2M | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-002534 |
| FY 2015 | $2.6M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-013340 |
| FY 2014 | $-592.7k | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002163 |
| FY 2013 | $204.9k | 2013-01-01 – 2013-12-31 | evidence 0001213900-14-001241 |
| FY 2012 | $74.2k | 2012-01-01 – 2012-12-31 | evidence 0001213900-13-001067 |
| FY 2011 | $-97.8k | 2011-01-01 – 2011-12-31 | evidence 0001213900-13-001067 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CYCLO THERAPEUTICS, INC. — all facts · Revenue · Operating Income